During shock, arterial hypotension, inadequate cardiac output and microcirculatory alterations lead to tissue hypoxia, multiple organ failure and death. Arterial lactate is considered as the best marker of tissue hypoxia. A lactate decrease during the first 6 hour is strongly associated with better outcome and may be used as a target for assessing the efficiency of shock resuscitation. The EIRUS system (Maquet Critical Care AB, 17154, Solna, Sweden) is a new device allowing the continuous measurement of venous lactate through a central venous catheter. However, before being used extensively, such device needs to be evaluated concerning its accuracy. The aim of the present study is to assess the reliability of this device.
Study Type
OBSERVATIONAL
Enrollment
29
continuous measurement of venous lactate through a central venous catheter by microdialysis
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France
Agreement
Agreement between sequential arterial blood lactate measurement and continuous venous lactate obtained by microdialysis
Time frame: Every 4hours for 48hours
Interchangeability
Interchangeability of the variations of the two methods using the trend interchangeability method
Time frame: Every 4hours for 48hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.